Advances in the Treatment of Movement Disorders with Botulinum Toxins

Dear Colleagues,

We have the honor of coordinating the preparation of a Special Issue of the journal Toxins, titled “Advances in the Treatment of Movement Disorders with Botulinum Toxins”.

This Special Issue will mainly focus on dystonia. In addition to articles devoted to classic, approved indications of botulinum toxin injections, we aim to collect works of high-quality research about poorly explored common conditions such as dystonic tremors or functional dystonia, as well as rare, unapproved indications including task-specific and oromandibular dystonia. Moreover, articles devoted to other movement disorders (mainly tremors and myoclonus) will be considered. We will pay close attention to works aimed at better understanding the duration during which injections remain effective and ways to optimize the results of this treatment. This issue will also cover advances in injection techniques or dose selection. Lastly, works dedicated to new forms of botulinum toxins will be welcome.

Indeed, we want to make this issue particularly diverse and innovative, with the objectives of attracting the interest of as many people as possible and also of offering vocations for young colleagues at a time when other fields of neurology are proving increasingly attractive. Now, please go ahead and pick up your pens and surprise us!

Dr. Alexandre Kreisler
Prof. Dr. Wolfgang Jost
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• rare forms of dystonia
• common but poorly explored forms of dystonia
• tremor
• myoclonus
• optimization of results
• duration of efficacy
• guidance
• injection techniques
• recombinant botulinum toxin